Gsk GSK
NYSE GSK
$50.13 +2.00 (+4.17%)
As of: Sep 14, 2026 · 2:19 PM EDT

Gsk (GSK) Cash & Equivalents (QoQ) (2009 - 2026)

Analysis

Gsk (GSK) Cash & Equivalents (QoQ) (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Asml Holding 618.86 Bn 602.88 Bn 5.90 Bn
2 Hsbc Holdings 361.40 Bn 361.40 Bn -
3 General Electric 329.38 Bn 320.03 Bn 6.95 Bn
4 Astrazeneca 253.73 Bn 248.44 Bn 12.86 Bn
5 Citigroup 228.07 Bn -2,074.24 Bn 24.75 Bn
6 Bhp 216.09 Bn 197.55 Bn -
7 Rio Tinto 203.71 Bn 199.33 Bn -
8 Diageo 197.36 Bn 195.32 Bn -
9 Unilever 139.15 Bn 132.12 Bn -
10 Gsk 101.53 Bn 101.53 Bn 15.97 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -10.23%
Mar 31, 2026 2.70%
Dec 31, 2025 1.60%
Sep 30, 2025 -7.37%
Jun 30, 2025 -14.61%
Mar 31, 2025 13.19%
Dec 31, 2024 19.77%
Sep 30, 2024 10.93%
Jun 30, 2024 5.64%
Mar 31, 2024 -2.88%
Dec 31, 2023 -9.45%
Sep 30, 2023 2.42%
Jun 30, 2023 11.86%
Mar 31, 2023 -19.56%
Dec 31, 2022 2.75%
Sep 30, 2022 -47.80%
Jun 30, 2022 1,488.33%
Mar 31, 2022 -91.10%
Dec 31, 2021 21.03%
Sep 30, 2021 -2.78%